Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: testing (1000), trialling (517)

Bevacizumab-Capecitabine

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Capeci
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Aflibercept
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

Procedure for bioimpedance with Bodystat 1500

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance syst
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-bioimpedance-with-Bodystat-1500.pdf

Cemiplimab

Description: Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metastatic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf

WHP Funding Call EOI_01.03.24

Description: Funding Call – Round 1 - PILOT Expression of Interest About Wessex Health Partners: 1. Wessex Health Partners (WHP) is the region’s academic health science strategic partnership o
Url: /Media/Southampton-Clinical-Research/Downloads/WHP-Funding-Call-EOI-01.03.24.docx

Standing Financial Instructions

Description: These Standing Financial Instructions (SFIs) are issued for the regulation of the conduct of Trust members and officers in relation to
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Finance/StandingFinancialInstructions.pdf

Person Spec Fellows TL Updated 2023

Description: EMPLOYMENT CRITERIA/PERSON SPECIFICATION The purpose of this specification is to identify the attributes required by applicants to perform the duties described i
Url: /Media/Southampton-Clinical-Research/Downloads/Person-Spec-Fellows-TL-Updated-2023.pdf

Atezolizumab-Bevacizumab-Carboplatin(AUC6)-Paclitaxel

Description: Chemotherapy Protocol LUNG CANCER ATEZOLIZUMAB-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen  Lung-Atezolizumab-Bevacizumab-Carboplatin (AUC6)-Pacli
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab-Bevacizumab-CarboplatinAUC6-Paclitaxel.pdf

Papers Trust Board - 30 January 2020

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 30/01/2020 9:00 - 11:45 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/Papers-Trust-Board-30-January-2020.pdf

Testing for gene variants in inherited breast, ovarian and prostate cancers - patient information

Description: Information about testing for gene variants in inherited breast, ovarian and prostate cancers.
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Testing-for-gene-variants-in-inherited-breast-ovarian-and-prostate-cancers-1980-PIL.pdf

81 to 90 of 149

Previous … 7 8 9 10 11 … Next